Previous posts in series: Wane’s world | #45
The week 46 COVID-19 vaccine surveillance report is now available from Public Health England and I’ve added the newest data to the implied efficacy graphs for the COVID-19 injectable pharmaceutical products, as revealed by the PHE data.
The graphs are showing a couple of some interesting trends, none of which I have an explanation for:
the decline in the implied “efficacy” against infection curve seems to be flattening out or reversing course and has actually ticked up into just barely positive territory for the 80+ group (recall “efficacy” against infection is graphed on the right-hand vertical axis);
the declines in the implied “efficacy” against hospitalization and death are also showing a flattening out or direction reversal this week (recall these are plotted against the left-hand vertical axis).
As usual the graphs below show the implied “vaccine” “efficacy” against infection, hospitalization, and death as revealed by the PHE data. The x-axis is week number, the y-axis “efficacy” percentage using the Pfizer/Moderna magic math. The left y-axis scaled from 50% to 100% applies to hospitalization and death. The right y-axis scaled from -140% to 100% applies to infection, because “efficacy” against infection is so dang bad. And as usual when “efficacy” is negative, it implies the COVID-19 injectable pharmaceutical products are causing, rather than preventing, infections.